Does COVID-19 pandemic impact cancer outcomes in metastatic setting? A comparative cohort study among metastatic patients treated at day care hospital.

Florian QuilanJustine LequesneFrançois CherifiEtienne BastienAdeline MorelCorinne DelcambreAngélique Da SilvaJean-Michel GrellardAlexandra LeconteAudrey FaveyrialBénédicte ClarisseFlorence Joly

Published in: Cancer medicine (2023)

Metastatic cancer patients treated during the first lockdown had a higher risk of disease progression 1 year after COVID-19 outbreak. However, oncological treatment adaptations or SARS-CoV-2 infections do not explain these results. A longer follow-up is needed to observe the impact on OS.

Keyphrases

squamous cell carcinoma
sars cov
small cell lung cancer
healthcare
papillary thyroid
prostate cancer
rectal cancer
emergency department
adverse drug
skeletal muscle
adipose tissue
childhood cancer
acute care
minimally invasive
affordable care act